Oncosec Medical Incorporated

Jean Campbell

Robert H Pierce

Eric Thomas Johnson

Andy Edward Denison

Robert Ryan Ragland

Christopher Scott Hayden

Douglas W Brown

David A Canton

Arya Bahrami

Richard J Connolly

Provided are plasmid vector constructs encoding multiple immunomodulatory proteins where each protein or component thereof can be expressed utilizing appropriate promotors and/or translation modifiers. Additional immunomodulatory proteins and genetic adjuvants containing shared tumor antigens can be added to further therapeutic potential as well as allow tracking of therapeutic treatment. Also provides are methods of expressing the plasmid constructs.

Plasmid constructs for heterologous protein expression and methods of use

An adaptive control method for controlling EP pulse parameters during electroporation (EP) of cells or tissue using an EP system includes providing a system for adaptive control to optimize EP pulse parameters including EP pulse parameters, applying voltage and current excitation signals to the cells, obtaining data from the current and voltage measurements, and processing the data to separate the desirable data from the undesirable data, extracting relevant features from the desirable data, applying at least a portion of the relevant features to a trained diagnostic model, estimating EP pulsing parameters based on an outcome of the applied relevant features, where the initialized EP pulsing parameters are based on the trained model and the relevant features, to optimize the EP pulsing parameters, and applying, by the generator, a first EP pulse based on the first pulsing parameters.

Systems and methods for improved tissue-sensing based electroporation

Growing community of inventors

Seattle, WA, United States of America

Jean Campbell